Atom Investors LP Spring Works Therapeutics, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$67.45 - $85.63 $1.38 Million - $1.75 Million	-20,398 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$65.1 - $93.59 $1.54 Million - $2.22 Million	-23,681 Reduced 53.72%	20,398 $1.5 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $1.85 Million - $2.98 Million	38,223 Added 652.72%	44,079 $3.2 Million
Q3 2020 Nov 13, 2020	BUY	$36.14 - $51.99 $211,635 - $304,453	5,856 New	5,856 $279,000

237

68.9M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.68B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.